Top Markets
#1 Purr Purr +64.03%
#2 Pons Pons +54.56%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 TENDIES TENDIES +40.15%
#5 Non-Playable Coin Non-Playable Coin +34.25%
#6 Cash Cat Cash Cat +32.21%
#7 Morpho Morpho +26.64%
#8 Kinetiq Kinetiq +23.90%
#9 StonkBroker StonkBroker +22.07%
#10 ApeX ApeX +21.54%
Coin of the day
Purr Purr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
F-star Therapeutics, Inc. F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTX
Clasificación en acciones #21013
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing Phase 1 clinical evaluation for patients with advanced malignancies. Founded in 2002, F-star Therapeutics, Inc. has its corporate headquarters situated in Cambridge, United Kingdom.
Precio por acción
$7.12
Última sincronización: 2023-03-08
Capitalización bursátil
$117.03M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
GB
Comercio F-star Therapeutics, Inc. (FSTX)

Categoría

Healthcare
Historial de rendimiento por dividendo de F-star Therapeutics, Inc. (FSTX)
Rendimiento por dividendo (TTM) de F-star Therapeutics, Inc. (símbolo bursátil: FSTX) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de F-star Therapeutics, Inc. (FSTX) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH